102 related articles for article (PubMed ID: 22450318)
1. Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma.
Zheng LY; Zhou DX; Lu J; Zhang WJ; Zou DJ
Biochem Biophys Res Commun; 2012 Apr; 420(3):680-4. PubMed ID: 22450318
[TBL] [Abstract][Full Text] [Related]
2. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.
Feng Z; Fan X; Jiao Y; Ban K
Hum Pathol; 2011 May; 42(5):659-68. PubMed ID: 21239045
[TBL] [Abstract][Full Text] [Related]
4. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
5. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
6. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
7. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
9. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern and clinicopathologic significance of NKD1 in human primary hepatocellular carcinoma.
Zhang S; Li J; Yin ZY; Liu PG; Zhao WX; Xie CR; Zhao BX; Wang XM
APMIS; 2015 Apr; 123(4):315-20. PubMed ID: 25706354
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
12. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.
Nagano H; Noguchi T; Inagaki K; Yoon S; Matozaki T; Itoh H; Kasuga M; Hayashi Y
Oncogene; 2003 Jul; 22(30):4656-63. PubMed ID: 12879010
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma.
Liang L; Guan J; Zeng Y; Wang J; Li X; Zhang X; Ding Y
Hum Pathol; 2011 Nov; 42(11):1603-12. PubMed ID: 21496865
[TBL] [Abstract][Full Text] [Related]
16. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
19. N-WASP is highly expressed in hepatocellular carcinoma and associated with poor prognosis.
Jin KM; Lu M; Liu FF; Gu J; Du XJ; Xing BC
Surgery; 2013 Apr; 153(4):518-25. PubMed ID: 23218879
[TBL] [Abstract][Full Text] [Related]
20. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
